MIV-170

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMIV-170
Drug Alias NameHIV polymerase inhibitors (Medivir/Bristol-Myers Squibb)non-nucleoside reverse transcriptase inhibitors (Medivir)NNRTIs (Medivir/Bristol-Myers Squibb)MIV-140MSK-076 +[6] 
ClassificationSmall molecules
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedivir ABBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A